Posted by Clinical Lab Products | Mar 15, 2010 | Miscellaneous |
Glycated hemoglobin (HbA1c) testing is one of the success stories of point-of-care diagnostics, and an area that will experience higher growth rates than other POC tests as a result of expert recommendations, new cases and booming mail-in test sales, according to a new Kalorama Information report.
Read MorePosted by Clinical Lab Products | Mar 7, 2010 | Clinical Chemistry, Clinical Chemistry Analyzers, Clinical Chemistry Test Kits, Miscellaneous |
Carolina Liquid Chemistries, GlycoMark Partner for New Diabetes Management Test Carolina Liquid Chemistries Corp will market the GlycoMark® blood test as one of a complete range of diabetes assays for the BioLis 24i benchtop chemistry analy
Read MorePosted by Clinical Lab Products | Mar 1, 2010 | Cancer, Miscellaneous |
Widely used biomarkers are not optimal in early detection of liver cancer, the third most common cause of cancer-related death worldwide, according to a new study published in this months Gastroenterology.
Read MorePosted by Clinical Lab Products | Feb 5, 2010 | Cancer, Miscellaneous |
OraSure and Roche Sign Commercialization Agreement for Oral Fluid DOA Assays OraSure Technologies Inc and Roche Diagnostics announced that the companies have signed an agreement for the worldwide commercialization of homogeneous fully automated
Read MorePosted by Clinical Lab Products | Jan 7, 2010 | Miscellaneous |
ADA Recommends A1C as Diagnostic Test for Diabetes The American Diabetes Association‘s new Clinical Practice Recommendations being published as a supplement to the January issue of Diabetes Care call for the addition of the A1C test as a means o
Read More